This is a golden age for infectious disease clinical trials. Novel technologies give us a deeper understanding of the molecular mechanisms of disease states, and the body's responses to them. Increased access to a wider global patient population and new tools to visualize large data sets enable new insights into how diseases spread.

The human immune system plays a pivotal role in conferring protective immunity to pathogenic microorganisms and cancer while its hyper-activation can result in serious inflammatory conditions such as autoimmunity.

Join our market access experts as they discuss the changing landscape and the role of a market access field team to support a drug's launch and lifecycle.

Gain a better understand of CMS policies and their implications as well as insight into commercial payers' management of biosimilars.

Learn more about a range of individual approaches that can be integrated to accelerate progress of complex Rare Disease studies across the world.

Covance Chief Scientific Officer Steven M. Anderson, PhD during our recent webinar where he discussed the spectrum of immunotherapy development considerations and their implications for drug developers.

Christos Petropoulos, Chief Scientific Officer, Monogram Biosciences and Vice President, LabCorp, discusses recent technological advances that have illuminated promising new approaches for immunogen design, vaccine delivery and vaccination.

Watch this summary video to see the recap of the Role of a CRO in Immuno-Oncology video series.

Watch this video to learn about genomic biomarkers in immuno-oncology drug development.

Watch this video to learn about companion and complementary diagnostics in immuno-oncology drug development.